Explora Biolabs Holdings, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Explora Biolabs Holdings, Inc. - overview
Established
2004
Location
San Diego, CA, US
Primary Industry
Pharmaceuticals
About
Explora Biolabs Holdings, Inc. is a specialized provider of vivarium rental facilities and management services, enabling research institutions to access tailored animal research environments and expertise. Founded in 2004 in San Diego, US, Explora BioLabs focuses on providing vivarium solutions. In April 2022, the company was acquired by Charles River Laboratories, Inc.
for USD 295 mn, enhancing Charles River's operations in Southern California, San Francisco, and Boston-Cambridge. CEO Nathaniel Paige leads the firm, which has become a key player in the vivarium service sector. Explora BioLabs, now part of Charles River, specializes in turnkey vivarium rental facilities and comprehensive vivarium management services. Their core offerings include CRADL® rentable vivarium labs, which range from a few cages to complete private rooms, staffed to meet specific research needs.
The company also provides staffing solutions and training programs for veterinarians, scientists, and lab technicians, serving clients across North America and Europe, including pharmaceutical companies, biotechnology firms, and academic institutions engaged in animal research. Explora BioLabs operates on a business-to-business model, primarily generating revenue through service agreements and rental contracts. Clients utilize vivarium space and staff under subscription-like agreements for ongoing management services. Pricing is structured around tiered models reflecting the complexity of vivarium services, with the CRADL® offering being a significant revenue contributor, catering to the demand for flexible laboratory environments in the life sciences sector.
The acquisition by Charles River Laboratories, Inc. positions Explora BioLabs for future growth, expanding its reach in Southern California, San Francisco, and Boston-Cambridge. The recent acquisition will enable further development of their offerings in these regions. The strategic use of the USD 295 mn from the latest funding round will support ongoing service enhancement and geographic expansion, aligning with market demands.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.explorabiolabs.com
Verticals
HealthTech
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Explora Biolabs Holdings, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Explora Biolabs Holdings, Inc. | - | ||||||||
| Add-on | Completed | Novalex Biotech Resources, LLC | - | ||||||||
| Buyout | Completed | Explora Biolabs Holdings, Inc. | - |
Displaying 1 - 3 of 3

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.